BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Services Contract Manufacturing

Amgen and Bushu Pharma Announce Expanded Supply Chain Partnership across Japan and Asia-Pacific Region

Bushu Pharmaceuticals Ltd. ("Bushu Pharma") has agreed on an expanded partnership with Amgen Inc. and Amgen K.K. to provide its "Gateway to Asia" serv...

November 25, 2021 | News

GreenLight Biosciences and Samsung Biologics announce collaboration to build capacity for messenger RNA Vaccine Manufacturing

GreenLight Biosciences (Nasdaq: ENVI), a biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible for human heal...

November 25, 2021 | News

OncoOne ,GenScript ProBio Enter Agreement for the Manufacturing of Monoclonal Antibody Drugs Targeting oxMIF

OncoOne, a biotechnology company focused on discovering precision medicines for cancer and other indications and GenScript ProBio, a leading CDMO in b...

November 17, 2021 | News

WuXi Biologics Launches a New GMP Commercial Drug Product Facility

Enhances drug product services for projects at various stages, with an emphasis on late and commercial stage production Increases up to 60 million vials...

November 01, 2021 | News

Catalent Further Expands Clinical Supply Network with New Facility in North America

The new facility marks the latest expansion to Catalent’s global clinical supply network, and follows the opening of a new site in Japan earlier this...

October 29, 2021 | News

Xcell Therapeutics opens an export route for cell therapy culture technology.

In a hair follicle, there are "dermal follicle papilla cells" that appear 3,000 grapes clustered together. The name was given because its outline resemble...

October 29, 2021 | News

WuXi Biologics Completes GMP Inspection by Health Canada for Drug Substance Facility

WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has completed a remote G...

October 28, 2021 | News

Samsung Biologics Reports Third Quarter 2021 Financial Results

Q3'21 revenue of KRW 450.7 billion increased 64% compared to Q3'20. Q3'21 operating profit of KRW 167.4 billion increased 196% compa...

October 27, 2021 | News

BD launches its second center of excellence in flow cytometry for clinical research at CMC In India

The CoE at CMC Vellorewill help to push the bounds of clinical research, provide opportunities for knowledge exchange and conduct diagnosis with highe...

October 25, 2021 | News

Chinese BioPharma I-Mab Expands U.S. Footprint with New R&D Site

I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel bi...

October 25, 2021 | News

Merck Completes New Viral Vector Contract Development Manufacturing Facility for Gene Therapy

Expansion in Carlsbad, California, USA, doubles production capacity to support commercialization and industrialization of viral vectors Investment ...

October 13, 2021 | News

Catalent Opens New Full-Service Clinical Supply Facility in Shiga, Japan

The 6,000 square-meter site will provide flexible clinical supply solutions, serving both local and global biotech and pharmaceutical companies. The facili...

October 10, 2021 | News

Vetter/Syntegon partnership scores PDA Drug Delivery Innovation Award

With demand for niche and orphan drugs continuing to surge, Vetter and Syntegon recently synced their expertise to advance the industry’s approach to...

October 07, 2021 | News

CPhI Report predicts record EBITDAs for CDMOs in 2022

Part one of the 2021 CPhI Annual Report predicts an increasingly bullish outlook for CDMOs in the next 2-3 years, with macro factors significantl...

September 28, 2021 | News

Stay Connected